
AI Robotics in Medicine
PublicTracking updates in AI Robotics in the healthcare industry
Harvard: AI Beats Doctors; Adoption Accelerates
Thursday, May 7, 2026
Harvard researchers report OpenAI’s o1 preview surpassed physicians in ER triage using standard EMRs (67% vs 50–55%) and reached 82% with richer data versus 70–79% for doctors, a gap not statistically significant; a small care-planning test also favored o1 (89% vs 34%) but needs verification. Adoption signals align: 25% of health systems have implemented AI, 59% plan to use it to improve interoperability, and 80% of MGMA Stat respondents expect AI literacy to be indispensable (3% say it already is). Clinical gains in imaging (0.59% vs 0.25% actionable lung-cancer detection) and uptake among UHNWIs of AI-enabled wearables point to near-term impact from triage to continuous monitoring—watch validation of clinical performance, interoperability build-out, and workforce readiness.
Tracking: Medicine Robotics · AI Medicine · AI Healthcare
Geography: United States, European Union, United Kingdom, Canada, China, Japan, South Korea, Israel, India, Singapore
1. Harvard trial finds AI beats doctors as healthcare AI adoption accelerates
Harvard Medical School and Beth Israel Deaconess researchers reported that OpenAI’s o1 preview outperformed physicians in emergency triage using only standard electronic medical records, achieving 67% diagnostic accuracy versus doctors’ 50–55% across 76 ER cases.
With richer information, o1 reached 82% accuracy while physicians scored 70–79%, a difference the team said was not statistically significant.
In a separate small test of five cases, o1’s longer-term care plans succeeded 89% versus clinicians’ 34%, though researchers cautioned more verification is needed.
Adoption signals are rising: an MGMA Stat poll of 494 respondents found 80% expect AI literacy to be indispensable (3% say it already is), and a 2024 HIMSS survey reports 25% of health systems have adopted AI and 59% plan to use it to improve interoperability.
Clinical gains are also emerging in imaging, with AI-aided lung cancer screening showing 0. 59% actionable detection versus 0.
25% unaided. Outside hospitals, UHNWIs are embracing AI-powered Withings wearables, with AI the “indispensable engine” for 24/7 remote monitoring and early anomaly detection.
Key facts:
- Harvard/BIDMC tested OpenAI’s o1 preview on 76 ER cases using EMRs.
- o1 triage accuracy 67% vs physicians’ 50–55% from standard electronic medical records.
- With detailed data, o1 hit 82% accuracy; physicians reached 70–79% (not statistically significant).
- In five cases, o1’s longer-term care plans succeeded 89% vs clinicians’ 34%.
- MGMA Stat poll (494): 80% expect AI indispensable; 3% say it already is.
Why it matters: Early triage is a high-impact bottleneck; AI gains there could reshape ED workflows, shorten time-to-diagnosis, and reallocate clinical effort. Broad interest and interoperability plans suggest health systems are primed to operationalize such tools alongside imaging AI and remote monitoring. UHNWIs’ embrace of continuous, AI-driven wearables previews a shift from episodic care to proactive surveillance that may diffuse into mainstream care. But the small-sample planning results demand larger, prospective validation and careful guardrails to manage safety, bias, and overreliance. Vendors that integrate EMR-linked triage, imaging support, and RPM analytics will be positioned to win; clinicians and payers will push for transparent performance, seamless EHR integration, and measurable outcomes before scaling.